Rekombinanter PD-L1 & VEGF-A Antikörper

Produktnummer ABIN7795552

Der Maus Bispecific anti-PD-L1 & VEGF-A Antikörper (Klon 10F-9G2-1-G6-31) (ABIN7795552) detektiert spezifisch PD-L1 & VEGF-A in ELISA, FACS, ICC, IHC, in vivo und WB. Dieser Antikörper reagiert spezifisch mit Proben aus Maus.

Kurzübersicht für Rekombinanter PD-L1 & VEGF-A Antikörper (ABIN7795552)

Target: PD-L1 & VEGF-A

Antikörpertyp: Recombinant Antibody

Reaktivität: Maus

Wirt: Maus

Klonalität: Bispecific

Konjugat: Unkonjugiert

Applikation: ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunohistochemistry (IHC), In vivo Studies (in vivo), Western Blotting (WB)

Güteklasse: In vivo Grade

Klon: 10F-9G2-1-G6-31

Produktdetails

Expressionssystem: Mammalian cells

Verwendungszweck: In Vivo Grade Recombinant Anti-mouse PD-L1 / VEGF-A Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone 10F.9G2.1 / G6-31)

Produktmerkmale: The rat anti-mouse PD-L1 monoclonal antibody 10F.9G2 (rat IgG2b kappa) reacts with the mouse PD-L1 protein (programmed death ligand-1, B7-H1 or CD274), a member of the B7 family of the Ig superfamily. PD-1 has two ligands, PD-L1 and PD-L2. It has been shown that in mouse models of melanoma, tumor growth can be transiently arrested via treatment with the anti-mouse PD-1 and anti-mouse PD-L1 antibodies which block the interaction between the PD-L1 protein and its receptor PD-1 protein. The 10F.9G2 monoclonal antibody blocks the binding of the mouse PD-L1 protein to the mouse PD-1 protein. It is under investigation how the recombinant anti-mouse PD-L1 / VEGF-A bispecific antibodies (10F.9G2 / G6-31) behave different from the individual monoclonal antibodies and their combination. Our recombinant anti-mouse PD-L1 / VEGF-A bispecific antibodies have a part (variable regions) or complete amino acid sequences of the rat anti-mouse PD-L1 antibody (hybridoma clone name or number: 10F.9G2) and the mouse anti-mouse VEGF antibody (hybridoma clone name or number: G6-31).

Aufreinigung: Protein A or G affinity column

Reinheit: >95 % by reducing SDS-PAGE

Endotoxin-Niveau: < 1 EU per 1 mg of the protein by the LAL method

Isotyp: IgG2c, L234A, L235A, P329G, kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: > 3 mg/mL

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Antigendetails

Target: PD-L1 & VEGF-A

Sub Type: Bispecific